Literature DB >> 8774420

Hypogammaglobulinaemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment.

G P Spickett, M M Gompels, P W Saunders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8774420      PMCID： PMC1073908          DOI： 10.1136/jnnp.60.4.459

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

Review 1.  Immunoglobulins in epilepsy.

Authors:  J A Aarli
Journal:  Springer Semin Immunopathol       Date:  1985

Review 2.  A review of carbamazepine's hematologic reactions and monitoring recommendations.

Authors:  J L Sobotka; B Alexander; B L Cook
Journal:  DICP       Date:  1990-12

3.  Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.

Authors:  N Başaran; F Hincal; E Kansu; A Ciğer
Journal:  Int J Immunopharmacol       Date:  1994-12

4.  Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF).

Authors:  R Weide; H Köppler; J Heymanns; K H Pflüger; K Havemann
Journal:  Br J Haematol       Date:  1992-04       Impact factor: 6.998

5.  Transient hypogammaglobulinemia in the adult. Functional assessment of T and B lymphocytes.

Authors:  M C Garcia Rodriguez; E G de la Concha; G Fontán; D Pascual-Salcedo; J Fernandez; J A Ojeda; A Garcia Diaz
Journal:  J Clin Lab Immunol       Date:  1983-05

6.  Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients.

Authors:  M Marcoli; G Gatti; G Ippoliti; M Lombardi; A Crema; M T Zocchi; F De Ponti; S Lecchini; G M Frigo
Journal:  Hum Toxicol       Date:  1985-03

7.  Carbamazepine effects on mononuclear blood cells in epileptic patients.

Authors:  N E Gilhus; R Matre
Journal:  Acta Neurol Scand       Date:  1986-09       Impact factor: 3.209
  7 in total
  7 in total

Review 1.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.

Authors:  Zenichiro Kato; Mizuho Watanabe; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2003-01-25       Impact factor: 3.183

3.  Antibody deficiency associated with carbamazepine.

Authors:  G Hayman; A Bansal
Journal:  BMJ       Date:  2002-11-23

4.  Oxcarbazepine-induced immunoglobulin deficiency.

Authors:  Adina Kay Knight; Charlotte Cunningham-Rundles
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

5.  Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia.

Authors:  Claire M Rice; Sarah L Johnston; David J Unsworth; Stuart C Glover; Matthew Donati; Shelley A Renowden; John Holloway; Sam D Lhatoo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

6.  Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.

Authors:  Melissa L Barker-Haliski; E Jill Dahle; Taylor D Heck; Timothy H Pruess; Fabiola Vanegas; Karen S Wilcox; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2015-03-09       Impact factor: 4.030

7.  B cell aplasia and hypogammaglobulinemia associated with levetiracetam.

Authors:  Hulya Ozdemir; Sua Sumer; Hakan Karabagli; Gokhan Akdemir; A Zafer Caliskaner; Hasibe Artac
Journal:  Ann Saudi Med       Date:  2018-01-09       Impact factor: 1.526
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.